Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.
Guo H, Zhong Y, Jackson AL, Clark LH, Kilgore J, Zhang L, Han J, Sheng X, Gilliam TP, Gehrig PA, Zhou C, Bae-Jump VL.
Guo H, et al. Among authors: jackson al.
Oncotarget. 2016 Apr 12;7(15):20338-56. doi: 10.18632/oncotarget.7934.
Oncotarget. 2016.
PMID: 26959121
Free PMC article.